Patent · US Active

Compounds, compositions, and methods

US10590114B2 · kind B2 · utility

3Cited by
4References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 21, 2018
Grant dateMar 17, 2020
Priority date—
Expiry dateMar 21, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/05
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure relates generally to LRRK2 inhibitors, or a pharmaceutically acceptable salt, deuterated analog, prodrug, tautomer, stereoisomer, or mixture of stereoisomers thereof, and methods of making and using thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.